# reload+after+2024-01-21 12:46:10.671730
address1§350 Technology Drive
address2§Suite 421
city§Pittsburgh
state§PA
zip§15219
country§United States
phone§412 763 3350
website§https://www.neubasetherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
fullTimeEmployees§37
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Dietrich A. Stephan Ph.D.', 'age': 53, 'title': 'Founder, CEO, President & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 836580, 'exercisedValue': 0, 'unexercisedValue': 992502}, {'maxAge': 1, 'name': 'Mr. Todd P. Branning', 'age': 53, 'title': 'CFO & Secretary', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 427445, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§5
compensationRisk§7
shareHolderRightsRisk§7
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.952
currency§USD
dateShortInterest§1702598400
forwardEps§-11.4
pegRatio§-0.02
exchange§NCM
quoteType§EQUITY
shortName§NeuBase Therapeutics, Inc.
longName§NeuBase Therapeutics, Inc.
firstTradeDateEpochUtc§1085751000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§dd3cf6cf-f9cd-3b1e-9591-aeb04f3b643b
gmtOffSetMilliseconds§-18000000
targetHighPrice§140.0
targetLowPrice§140.0
targetMeanPrice§140.0
targetMedianPrice§140.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§7.211
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
